An in-depth look at this medical topic, providing essential context for patients and caregivers.
General Medical Overview
Klatskin tumor: A condition categorized under Rare Abdominal & Miscellaneous.
Klatskin tumor is a cholangiocarcinoma arising at the confluence of the right and left hepatic ducts (hilar cholangiocarcinoma). For detailed information on diagnosis, treatment, and prognosis, please see the cholangiocarcinoma page, which covers all bile duct cancer types comprehensively.
Typical Treatment Roadmap
Detection
Symptoms and initial checkup.
Diagnosis
Biopsy and clinical imaging.
Treatment
Therapy (Surgery, Chemo, etc.)
Monitoring
Follow-up and recovery.
Clinical Manifestation (Main Symptoms)
Clinically, the initial presentation of Klatskin tumor often manifests with Fatigue, Weight Loss, Pain and Indigestion.
Advanced Stage Signs (Warning)
Painless progressive jaundice, pruritus, clay-colored stools, dark urine, and cholangitis.
Diagnostic Procedures
MRCP, ERCP with brush cytology, CT/MRI, and CA 19-9 tumor marker.
Medical Risk Factors
Primary sclerosing cholangitis, liver fluke infection, choledochal cysts, and chronic biliary disease.
Therapeutic Approach
Surgical resection when possible. Liver transplant under strict protocols for selected patients. Gemcitabine/cisplatin + durvalumab for unresectable disease.
Medical Breakthroughs & Hope
Liver transplant protocols for Klatskin tumors have achieved remarkable results in selected patients, offering the chance for long-term cure in a disease previously considered uniformly fatal.
Prognosis & Efficacy95%
R0 surgical resection achieves approximately 30-40% 5-year survival. Selected patients undergoing liver transplant protocol can achieve up to 65% 5-year survival.
Myth vs. Clinical Reality
Myth / Fiction
All jaundice in adults is caused by gallstones.
Fact / Reality
Painless progressive jaundice, especially in older adults, should raise suspicion for biliary malignancy including Klatskin tumor.
Myth / Fiction
Bile duct cancer is always inoperable.
Fact / Reality
With expert hepatobiliary surgery, many Klatskin tumors are resectable, and transplant protocols offer additional curative options.
Frequently Asked Questions (FAQ)
Why is it named Klatskin?
Named after Gerald Klatskin, who characterized this biliary confluence tumor in 1965.
Is transplant possible?
Yes, for selected patients who meet strict criteria and respond to neoadjuvant chemoradiation, liver transplantation can be curative.
Why does it cause jaundice?
Its location at the bile duct junction blocks bile drainage from both sides of the liver, causing progressive jaundice.
How is it staged?
The Bismuth-Corlette classification describes the extent of ductal involvement, which determines surgical approach and resectability.
Is ERCP necessary?
ERCP with biliary stenting relieves jaundice while providing tissue for cytological diagnosis. It is a key diagnostic and therapeutic procedure.